{"id":168253,"date":"2019-03-25T15:02:51","date_gmt":"2019-03-25T14:02:51","guid":{"rendered":"https:\/\/innovationorigins.com\/?p=168253"},"modified":"2019-03-25T15:02:51","modified_gmt":"2019-03-25T14:02:51","slug":"cytosmart-haalt-52-miljoen-euro-op-voor-productinnovatie-en-groei","status":"publish","type":"post","link":"https:\/\/ioplus.nl\/archive\/nl\/cytosmart-haalt-52-miljoen-euro-op-voor-productinnovatie-en-groei\/","title":{"rendered":"CytoSMART haalt 5,2 miljoen euro op voor productinnovatie en groei"},"content":{"rendered":"<p>Het Eindhovense bedrijf <a href=\"https:\/\/innovationorigins.com\/nl\/cytosmart-maakt-een-eind-aan-cellen-tellen-als-menselijke-dagtaak\/\">CytoSMART<\/a>, dat digitale microscopen voor het monitoren van celkweekprocessen ontwikkelt en ontwerpt, heeft een groeifinanciering ontvangen van 5,2 miljoen euro. Dat geld komt van\u00a0Holland Capital, BOM Brabant Ventures en Eindhoven Venture Capital Fund II, waarvan de eerste twee al eerder in het bedrijf hebben geinvesteerd. Met de financiering kan CytoSMART het product verder ontwikkelen en internationaal aan de slag met marketing en sales.<\/p>\n<p>Joffry Maltha, CEO van CytoSMART: \u201cDe omzet is sinds de Series A investeringsronde in 2016 met ruim 300% gegroeid. Om deze groei door te zetten is het van belang dat we de komende jaren onze producten blijven innoveren en meer gaan investeren in onze marketing en sales activiteiten. Dat betekent dat we fors inzetten op nieuwe applicaties voor beeldanalyse en doorontwikkeling van de hardware.\u201d<\/p>\n<p>Het bedrijf heeft drie microscopen ontwikkeld waarmee onderzoekers hun celkweken digitaal en op afstand kunnen tellen, screenen, inspecteren en filmen. Daarnaast kan je met software van CytoSMART experimenten uitvoeren met de beelden van de microscopen.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Het Eindhovense bedrijf CytoSMART, dat digitale microscopen voor het monitoren van celkweekprocessen ontwikkelt en ontwerpt, heeft een groeifinanciering ontvangen van 5,2 miljoen euro. Dat geld komt van\u00a0Holland Capital, BOM Brabant Ventures en Eindhoven Venture Capital Fund II, waarvan de eerste twee al eerder in het bedrijf hebben geinvesteerd. Met de financiering kan CytoSMART het product [&hellip;]<\/p>\n","protected":false},"author":1632,"featured_media":500086,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"advgb_blocks_editor_width":"","advgb_blocks_columns_visual_guide":"","footnotes":""},"categories":[1039],"tags":[7191],"location":[],"article_type":[],"serie":[],"archives":[],"internal_archives":[],"reboot-archive":[],"class_list":["post-168253","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-sustainability-nl-nl","tag-cytosmart"],"blocksy_meta":[],"acf":{"subtitle":"","text_display_homepage":false},"author_meta":{"display_name":"Frans van Beveren","author_link":"https:\/\/ioplus.nl\/archive\/author\/frans-van-beveren\/"},"featured_img":"https:\/\/ioplus.nl\/archive\/wp-content\/uploads\/2016\/06\/ZTnDDx6N-BvOF-2013_0405_ER-rechten-CytoSMART-HR-.jpg","coauthors":[],"tax_additional":{"categories":{"linked":["<a href=\"https:\/\/ioplus.nl\/archive\/nl\/category\/sustainability-nl-nl\/\" class=\"advgb-post-tax-term\">Sustainability<\/a>"],"unlinked":["<span class=\"advgb-post-tax-term\">Sustainability<\/span>"]},"tags":{"linked":["<a href=\"https:\/\/ioplus.nl\/archive\/nl\/category\/sustainability-nl-nl\/\" class=\"advgb-post-tax-term\">CytoSMART<\/a>"],"unlinked":["<span class=\"advgb-post-tax-term\">CytoSMART<\/span>"]}},"comment_count":"0","relative_dates":{"created":"Posted 7 years ago","modified":"Updated 7 years ago"},"absolute_dates":{"created":"Posted on March 25, 2019","modified":"Updated on March 25, 2019"},"absolute_dates_time":{"created":"Posted on March 25, 2019 3:02 pm","modified":"Updated on March 25, 2019 3:02 pm"},"featured_img_caption":"","series_order":"","_links":{"self":[{"href":"https:\/\/ioplus.nl\/archive\/wp-json\/wp\/v2\/posts\/168253","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ioplus.nl\/archive\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ioplus.nl\/archive\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ioplus.nl\/archive\/wp-json\/wp\/v2\/users\/1632"}],"replies":[{"embeddable":true,"href":"https:\/\/ioplus.nl\/archive\/wp-json\/wp\/v2\/comments?post=168253"}],"version-history":[{"count":0,"href":"https:\/\/ioplus.nl\/archive\/wp-json\/wp\/v2\/posts\/168253\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ioplus.nl\/archive\/wp-json\/wp\/v2\/media\/500086"}],"wp:attachment":[{"href":"https:\/\/ioplus.nl\/archive\/wp-json\/wp\/v2\/media?parent=168253"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ioplus.nl\/archive\/wp-json\/wp\/v2\/categories?post=168253"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ioplus.nl\/archive\/wp-json\/wp\/v2\/tags?post=168253"},{"taxonomy":"location","embeddable":true,"href":"https:\/\/ioplus.nl\/archive\/wp-json\/wp\/v2\/location?post=168253"},{"taxonomy":"article_type","embeddable":true,"href":"https:\/\/ioplus.nl\/archive\/wp-json\/wp\/v2\/article_type?post=168253"},{"taxonomy":"serie","embeddable":true,"href":"https:\/\/ioplus.nl\/archive\/wp-json\/wp\/v2\/serie?post=168253"},{"taxonomy":"archives","embeddable":true,"href":"https:\/\/ioplus.nl\/archive\/wp-json\/wp\/v2\/archives?post=168253"},{"taxonomy":"internal_archives","embeddable":true,"href":"https:\/\/ioplus.nl\/archive\/wp-json\/wp\/v2\/internal_archives?post=168253"},{"taxonomy":"reboot-archive","embeddable":true,"href":"https:\/\/ioplus.nl\/archive\/wp-json\/wp\/v2\/reboot-archive?post=168253"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}